An update on the management of hepatitis C: guidelines for protease inhibitor-based triple therapy from the Latin American Association for the Study of the Liver
Hepatitis C is a common cause of end-stage liver disease, and the main indication for liver transplantation in Latin America. Treatment of hepatitis C infected patients improves important long-term outcomes as mortality. Sustained viral response is reached in near 50% of patients with the previous m...
| Autores principales: | , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Artículo |
| Lenguaje: | inglés |
| Publicado: |
2013
|
| Materias: | |
| Acceso en línea: | http://eprints.uanl.mx/23451/1/23451.pdf |
| _version_ | 1824416886717153280 |
|---|---|
| author | Chávez Tapia, Norberto C. Ridruejo, Ezequiel De Mattos, Angelo Alves Bessone, Fernando Daruich, Jorge Sánchez Ávila, Juan F. Cheinquer, Hugo Zapata, Rodrigo Uribe Esquivel, Misael Bosques Padilla, Francisco Javier Gadano, Adrián Soza, Alejandro Dávalos Moscol, Milagros Marroni, Claudio Muñoz Espinoza, Linda Castro Narro, Graciela Paraná, Raymundo Méndez Sánchez, Nahum |
| author_facet | Chávez Tapia, Norberto C. Ridruejo, Ezequiel De Mattos, Angelo Alves Bessone, Fernando Daruich, Jorge Sánchez Ávila, Juan F. Cheinquer, Hugo Zapata, Rodrigo Uribe Esquivel, Misael Bosques Padilla, Francisco Javier Gadano, Adrián Soza, Alejandro Dávalos Moscol, Milagros Marroni, Claudio Muñoz Espinoza, Linda Castro Narro, Graciela Paraná, Raymundo Méndez Sánchez, Nahum |
| author_sort | Chávez Tapia, Norberto C. |
| collection | Repositorio Institucional |
| description | Hepatitis C is a common cause of end-stage liver disease, and the main indication for liver transplantation in Latin America. Treatment of hepatitis C infected patients improves important long-term outcomes as mortality. Sustained viral response is reached in near 50% of patients with the previous management based in pegylated interferon and ribavirin. Recently new drugs were available increasing sustained viral response significantly, changing the standard of care to triple therapy. This guidelines provides a framework for practitioner in Latin America, to the management of patients with hepatitis C chronic infection. |
| format | Article |
| id | eprints-23451 |
| institution | UANL |
| language | English |
| publishDate | 2013 |
| record_format | eprints |
| spelling | eprints-234512024-12-09T19:50:52Z http://eprints.uanl.mx/23451/ An update on the management of hepatitis C: guidelines for protease inhibitor-based triple therapy from the Latin American Association for the Study of the Liver Chávez Tapia, Norberto C. Ridruejo, Ezequiel De Mattos, Angelo Alves Bessone, Fernando Daruich, Jorge Sánchez Ávila, Juan F. Cheinquer, Hugo Zapata, Rodrigo Uribe Esquivel, Misael Bosques Padilla, Francisco Javier Gadano, Adrián Soza, Alejandro Dávalos Moscol, Milagros Marroni, Claudio Muñoz Espinoza, Linda Castro Narro, Graciela Paraná, Raymundo Méndez Sánchez, Nahum RC Medicina Interna, Psiquiatría, Neurología Hepatitis C is a common cause of end-stage liver disease, and the main indication for liver transplantation in Latin America. Treatment of hepatitis C infected patients improves important long-term outcomes as mortality. Sustained viral response is reached in near 50% of patients with the previous management based in pegylated interferon and ribavirin. Recently new drugs were available increasing sustained viral response significantly, changing the standard of care to triple therapy. This guidelines provides a framework for practitioner in Latin America, to the management of patients with hepatitis C chronic infection. 2013-03 Article PeerReviewed text en cc_by_nc_nd http://eprints.uanl.mx/23451/1/23451.pdf http://eprints.uanl.mx/23451/1.haspreviewThumbnailVersion/23451.pdf Chávez Tapia, Norberto C. y Ridruejo, Ezequiel y De Mattos, Angelo Alves y Bessone, Fernando y Daruich, Jorge y Sánchez Ávila, Juan F. y Cheinquer, Hugo y Zapata, Rodrigo y Uribe Esquivel, Misael y Bosques Padilla, Francisco Javier y Gadano, Adrián y Soza, Alejandro y Dávalos Moscol, Milagros y Marroni, Claudio y Muñoz Espinoza, Linda y Castro Narro, Graciela y Paraná, Raymundo y Méndez Sánchez, Nahum (2013) An update on the management of hepatitis C: guidelines for protease inhibitor-based triple therapy from the Latin American Association for the Study of the Liver. Annals of hepatology, 12 (2). S3-S35. ISSN 1665-2681 http://doi.org/10.1016/S1665-2681(19)31404-8 doi:10.1016/S1665-2681(19)31404-8 |
| spellingShingle | RC Medicina Interna, Psiquiatría, Neurología Chávez Tapia, Norberto C. Ridruejo, Ezequiel De Mattos, Angelo Alves Bessone, Fernando Daruich, Jorge Sánchez Ávila, Juan F. Cheinquer, Hugo Zapata, Rodrigo Uribe Esquivel, Misael Bosques Padilla, Francisco Javier Gadano, Adrián Soza, Alejandro Dávalos Moscol, Milagros Marroni, Claudio Muñoz Espinoza, Linda Castro Narro, Graciela Paraná, Raymundo Méndez Sánchez, Nahum An update on the management of hepatitis C: guidelines for protease inhibitor-based triple therapy from the Latin American Association for the Study of the Liver |
| thumbnail | https://rediab.uanl.mx/themes/sandal5/images/online.png |
| title | An update on the management of hepatitis C: guidelines for protease inhibitor-based triple therapy from the Latin American Association for the Study of the Liver |
| title_full | An update on the management of hepatitis C: guidelines for protease inhibitor-based triple therapy from the Latin American Association for the Study of the Liver |
| title_fullStr | An update on the management of hepatitis C: guidelines for protease inhibitor-based triple therapy from the Latin American Association for the Study of the Liver |
| title_full_unstemmed | An update on the management of hepatitis C: guidelines for protease inhibitor-based triple therapy from the Latin American Association for the Study of the Liver |
| title_short | An update on the management of hepatitis C: guidelines for protease inhibitor-based triple therapy from the Latin American Association for the Study of the Liver |
| title_sort | update on the management of hepatitis c guidelines for protease inhibitor based triple therapy from the latin american association for the study of the liver |
| topic | RC Medicina Interna, Psiquiatría, Neurología |
| url | http://eprints.uanl.mx/23451/1/23451.pdf |
| work_keys_str_mv | AT chaveztapianorbertoc anupdateonthemanagementofhepatitiscguidelinesforproteaseinhibitorbasedtripletherapyfromthelatinamericanassociationforthestudyoftheliver AT ridruejoezequiel anupdateonthemanagementofhepatitiscguidelinesforproteaseinhibitorbasedtripletherapyfromthelatinamericanassociationforthestudyoftheliver AT demattosangeloalves anupdateonthemanagementofhepatitiscguidelinesforproteaseinhibitorbasedtripletherapyfromthelatinamericanassociationforthestudyoftheliver AT bessonefernando anupdateonthemanagementofhepatitiscguidelinesforproteaseinhibitorbasedtripletherapyfromthelatinamericanassociationforthestudyoftheliver AT daruichjorge anupdateonthemanagementofhepatitiscguidelinesforproteaseinhibitorbasedtripletherapyfromthelatinamericanassociationforthestudyoftheliver AT sanchezavilajuanf anupdateonthemanagementofhepatitiscguidelinesforproteaseinhibitorbasedtripletherapyfromthelatinamericanassociationforthestudyoftheliver AT cheinquerhugo anupdateonthemanagementofhepatitiscguidelinesforproteaseinhibitorbasedtripletherapyfromthelatinamericanassociationforthestudyoftheliver AT zapatarodrigo anupdateonthemanagementofhepatitiscguidelinesforproteaseinhibitorbasedtripletherapyfromthelatinamericanassociationforthestudyoftheliver AT uribeesquivelmisael anupdateonthemanagementofhepatitiscguidelinesforproteaseinhibitorbasedtripletherapyfromthelatinamericanassociationforthestudyoftheliver AT bosquespadillafranciscojavier anupdateonthemanagementofhepatitiscguidelinesforproteaseinhibitorbasedtripletherapyfromthelatinamericanassociationforthestudyoftheliver AT gadanoadrian anupdateonthemanagementofhepatitiscguidelinesforproteaseinhibitorbasedtripletherapyfromthelatinamericanassociationforthestudyoftheliver AT sozaalejandro anupdateonthemanagementofhepatitiscguidelinesforproteaseinhibitorbasedtripletherapyfromthelatinamericanassociationforthestudyoftheliver AT davalosmoscolmilagros anupdateonthemanagementofhepatitiscguidelinesforproteaseinhibitorbasedtripletherapyfromthelatinamericanassociationforthestudyoftheliver AT marroniclaudio anupdateonthemanagementofhepatitiscguidelinesforproteaseinhibitorbasedtripletherapyfromthelatinamericanassociationforthestudyoftheliver AT munozespinozalinda anupdateonthemanagementofhepatitiscguidelinesforproteaseinhibitorbasedtripletherapyfromthelatinamericanassociationforthestudyoftheliver AT castronarrograciela anupdateonthemanagementofhepatitiscguidelinesforproteaseinhibitorbasedtripletherapyfromthelatinamericanassociationforthestudyoftheliver AT paranaraymundo anupdateonthemanagementofhepatitiscguidelinesforproteaseinhibitorbasedtripletherapyfromthelatinamericanassociationforthestudyoftheliver AT mendezsancheznahum anupdateonthemanagementofhepatitiscguidelinesforproteaseinhibitorbasedtripletherapyfromthelatinamericanassociationforthestudyoftheliver AT chaveztapianorbertoc updateonthemanagementofhepatitiscguidelinesforproteaseinhibitorbasedtripletherapyfromthelatinamericanassociationforthestudyoftheliver AT ridruejoezequiel updateonthemanagementofhepatitiscguidelinesforproteaseinhibitorbasedtripletherapyfromthelatinamericanassociationforthestudyoftheliver AT demattosangeloalves updateonthemanagementofhepatitiscguidelinesforproteaseinhibitorbasedtripletherapyfromthelatinamericanassociationforthestudyoftheliver AT bessonefernando updateonthemanagementofhepatitiscguidelinesforproteaseinhibitorbasedtripletherapyfromthelatinamericanassociationforthestudyoftheliver AT daruichjorge updateonthemanagementofhepatitiscguidelinesforproteaseinhibitorbasedtripletherapyfromthelatinamericanassociationforthestudyoftheliver AT sanchezavilajuanf updateonthemanagementofhepatitiscguidelinesforproteaseinhibitorbasedtripletherapyfromthelatinamericanassociationforthestudyoftheliver AT cheinquerhugo updateonthemanagementofhepatitiscguidelinesforproteaseinhibitorbasedtripletherapyfromthelatinamericanassociationforthestudyoftheliver AT zapatarodrigo updateonthemanagementofhepatitiscguidelinesforproteaseinhibitorbasedtripletherapyfromthelatinamericanassociationforthestudyoftheliver AT uribeesquivelmisael updateonthemanagementofhepatitiscguidelinesforproteaseinhibitorbasedtripletherapyfromthelatinamericanassociationforthestudyoftheliver AT bosquespadillafranciscojavier updateonthemanagementofhepatitiscguidelinesforproteaseinhibitorbasedtripletherapyfromthelatinamericanassociationforthestudyoftheliver AT gadanoadrian updateonthemanagementofhepatitiscguidelinesforproteaseinhibitorbasedtripletherapyfromthelatinamericanassociationforthestudyoftheliver AT sozaalejandro updateonthemanagementofhepatitiscguidelinesforproteaseinhibitorbasedtripletherapyfromthelatinamericanassociationforthestudyoftheliver AT davalosmoscolmilagros updateonthemanagementofhepatitiscguidelinesforproteaseinhibitorbasedtripletherapyfromthelatinamericanassociationforthestudyoftheliver AT marroniclaudio updateonthemanagementofhepatitiscguidelinesforproteaseinhibitorbasedtripletherapyfromthelatinamericanassociationforthestudyoftheliver AT munozespinozalinda updateonthemanagementofhepatitiscguidelinesforproteaseinhibitorbasedtripletherapyfromthelatinamericanassociationforthestudyoftheliver AT castronarrograciela updateonthemanagementofhepatitiscguidelinesforproteaseinhibitorbasedtripletherapyfromthelatinamericanassociationforthestudyoftheliver AT paranaraymundo updateonthemanagementofhepatitiscguidelinesforproteaseinhibitorbasedtripletherapyfromthelatinamericanassociationforthestudyoftheliver AT mendezsancheznahum updateonthemanagementofhepatitiscguidelinesforproteaseinhibitorbasedtripletherapyfromthelatinamericanassociationforthestudyoftheliver |